The Board of Directors of the Company at its meeting held on 21st August, 2025, subject to requisite approvals/consents, approved the Composite Scheme of Arrangement ('Scheme') under Section 230 to 232 and other applicable provisions of the Companies Act, 2013 ('Act'). The details of Composite Scheme of Arrangement, in brief, are as follows: (i) The demerger of Laurus Synthesis Private Limited ('LSPL' or 'Transferor Company' or 'Demerged Company'), a wholly owned subsidiary of Laurus Labs Limited, whereby the Identified Business Undertaking i.e., Unit-1 of LSPL shall be demerged and be merged with Sriam Labs Private Limited ('Sriam' or 'Resulting Company'), a wholly owned subsidiary of Laurus Labs Limited; and (ii) Amalgamation of the Remaining Business Undertaking of LSPL (i.e., entire LSPL excluding Unit- 1) with Laurus Labs Limited ('Laurus' or 'Transferee Company') and dissolution of Transferor Company/LSPL without going through the process of winding up under the provisions of the Ac Please see the annexed enclosure (As per BSE Announcement Dated on 05/09/2025)